Glioblastoma and Anaplastic Astrocytoma: Differentiation Using MRI Texture Analysis

被引:19
|
作者
Tian, Zerong [1 ]
Chen, Chaoyue [1 ]
Fan, Yimeng [2 ,3 ,4 ]
Ou, Xuejin [5 ]
Wang, Jian [6 ]
Ma, Xuelei [7 ,8 ,9 ]
Xu, Jianguo [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, Dept Ophthalmol, West China Hosp, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China
[4] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Sichuan, Peoples R China
[5] Sichuan Univ, West China Hosp, West China Sch Med, Chengdu, Sichuan, Peoples R China
[6] Nanjing Univ Sci & Technol, Sch Comp Sci, Nanjing, Jiangsu, Peoples R China
[7] Sichuan Univ, Dept Biotherapy, Canc Ctr, West China Hosp, Chengdu, Sichuan, Peoples R China
[8] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China
[9] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Canc Ctr, Chengdu, Sichuan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2019年 / 9卷
关键词
texture features; machine learning; linear discriminant analysis; differential diagnosis; glioblastoma; anaplastic astrocytoma; CENTRAL-NERVOUS-SYSTEM; CANCER STATISTICS; MALIGNANT GLIOMAS; FEATURES; CLASSIFICATION; RADIOTHERAPY; MULTIFORME; DIAGNOSIS;
D O I
10.3389/fonc.2019.00876
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Glioblastoma and anaplastic astrocytoma (ANA) are two of the most common primary brain tumors in adults. The differential diagnosis is important for treatment recommendations and prognosis assessment. This study aimed to assess the discriminative ability of texture analysis using machine learning to distinguish glioblastoma from ANA. Methods: A total of 123 patients with glioblastoma (n = 76) or ANA (n = 47) were enrolled in this study. Texture features were extracted from contrast-enhanced Magnetic Resonance (MR) images using LifeX package. Three independent feature-selection methods were performed to select the most discriminating parameters:Distance Correlation, least absolute shrinkage and selection operator (LASSO), and gradient correlation decision tree (GBDT). These selected features (datasets) were then randomly split into the training and the validation group at the ratio of 4:1 and were fed into linear discriminant analysis (LDA), respectively, and independently. The standard sensitivity, specificity, the areas under receiver operating characteristic curve (AUC) and accuracy were calculated for both training and validation group. Results: All three models (Distance Correlation + LDA, LASSO + LDA and GBDT + LDA) showed promising ability to discriminate glioblastoma from ANA, with AUCs >= 0.95 for both the training and the validation group using LDA algorithm and no overfitting was observed. LASSO + LDA showed the best discriminative ability in horizontal comparison among three models. Conclusion: Our study shows that MRI texture analysis using LDA algorithm had promising ability to discriminate glioblastoma from ANA. Multi-center studies with greater number of patients are warranted in future studies to confirm the preliminary result.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] CEREBROSPINAL-FLUID POLYAMINES IN PATIENTS WITH GLIOBLASTOMA-MULTIFORME AND ANAPLASTIC ASTROCYTOMA
    FULTON, DS
    LEVIN, VA
    LUBICH, WP
    WILSON, CB
    MARTON, LJ
    CANCER RESEARCH, 1980, 40 (09) : 3293 - 3296
  • [42] T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma
    Auer, Timo Alexander
    Kern, Maike
    Fehrenbach, Uli
    Tanyldizi, Yasemin
    Misch, Martin
    Wiener, Edzard
    NEURORADIOLOGY JOURNAL, 2021, 34 (05): : 392 - 400
  • [43] Development of Secondary Malignant Neoplasms in Pediatric Patients Diagnosed With Glioblastoma or Anaplastic Astrocytoma
    Madden, N. A.
    Marascio, J. A.
    Zaenger, D.
    Rabatic, B.
    McDonough, C.
    Johnson, T. S.
    Kong, F. M.
    Dasher, B. G.
    Martin, W.
    Stewart, J. G.
    Howington, J.
    Marchan, E. M.
    Shaaban, S.
    Huang, K.
    Al-Basheer, A.
    Amoush, A.
    Green, A.
    Pishgou, M.
    Ferguson, C. L.
    Mourad, W. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E555 - E555
  • [44] A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme
    Larner, J
    Jane, J
    Laws, E
    Packer, R
    Myers, C
    Shaffrey, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (06): : 579 - 583
  • [45] Differentiation between supratentorial pilocytic astrocytoma and extraventricular ependymoma using multiparametric MRI
    Zhou, Xiaofang
    Su, Yan
    Huang, Wanrong
    Lin, Xiaojun
    Xing, Zhen
    Cao, Dairong
    ACTA RADIOLOGICA, 2022, 63 (12) : 1661 - 1668
  • [46] Differentiation of Pilocytic Astrocytoma from Glioblastoma using a Machine-Learning framework based upon quantitative T1 perfusion MRI
    Vats, Neha
    Sengupta, Anirban
    Gupta, Rakesh K.
    Patir, Rana
    Vaishya, Sandeep
    Ahlawat, Sunita
    Saini, Jitender
    Agarwal, Sumeet
    Singh, Anup
    MAGNETIC RESONANCE IMAGING, 2023, 98 : 76 - 82
  • [47] Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI
    Chawla, Sanjeev
    Wang, Sumei
    Mohan, Suyash
    Nasrallah, MacLean
    Verma, Gaurav
    Brem, Steven
    O'Rourke, Donald M.
    Wolf, Ronald L.
    Poptani, Harish
    Nabavizadeh, S. Ali
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2019, 49 (01) : 184 - 194
  • [48] Differentiation of progressive disease from pseudoprogression using MRI histogram analysis in patients with treated glioblastoma
    Yildirim, Mustafa
    Baykara, Murat
    ACTA NEUROLOGICA BELGICA, 2022, 122 (02) : 363 - 368
  • [49] Differentiation of progressive disease from pseudoprogression using MRI histogram analysis in patients with treated glioblastoma
    Mustafa Yildirim
    Murat Baykara
    Acta Neurologica Belgica, 2022, 122 : 363 - 368
  • [50] CONCOMITANT CHEMORADIOTHERAPY, NEUTRON BOOST, AND ADJUVANT CHEMOTHERAPY FOR ANAPLASTIC ASTROCYTOMA AND GLIOBLASTOMA-MULTIFORME
    KRISHNASAMY, S
    VOKES, EE
    DOHRMANN, GJ
    MICK, R
    GARCIA, JC
    KOLKER, JD
    WOLLMANN, RL
    HEKMATPANAH, J
    WEICHSELBAUM, RR
    CANCER INVESTIGATION, 1995, 13 (05) : 453 - 459